| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.32B | +0.6% | +6.9% |
| R&D Expense | $17.3M | -4.3% | +25.4% |
| SG&A Expense | $62.3M | -15.8% | +1.5% |
| Operating Income | $4.0M | +269.0% | +148.2% |
| Pre-tax Income | $4.4M | +343.0% | +156.7% |
| Income Tax | $932K | +99.1% | +169.9% |
| Net Income | $3.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $112.8M | +19.3% | -13.5% |
| Accounts Receivable | $123.8M | -15.3% | +17.7% |
| Current Assets | $323.1M | -6.3% | +4.4% |
| Total Assets | $458.7M | -4.7% | +6.0% |
| Current Liabilities | $223.5M | -15.0% | +0.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $104.8M | — | — |
| Capital Expenditures | $7.7M | — | — |
| Investing Cash Flow | -$20.5M | — | — |
| Financing Cash Flow | -$68.8M | — | — |
| Free Cash Flow | $97.1M | — | — |
| +252.6% |
| +141.1% |
| EPS (Basic) | $0.02 | +300.0% | +133.3% |
| EPS (Diluted) | $0.02 | +300.0% | +133.3% |
| $223.5M |
| -15.0% |
| +0.9% |
| Stockholders' Equity | $235.3M | +7.7% | +11.4% |